Erectile Dysfunction (ED) - Renal and Urology News

Erectile Dysfunction

Erectile Dysfunction Linked to Atopic Dermatitis

Jody A. Charnow January 19, 2012

Men with erectile dysfunction (ED) are more likely to have had prior atopic dermatitis than men without ED, according to study findings published online in the Journal of Sexual Medicine.

Erectile Dysfunction Linked to Previous Psoriasis Diagnosis

January 14, 2012

Men with erectile dysfunction more likely to have been previously diagnosed with psoriasis

Erectile Dysfunction Highly Prevalent Among Men on Hemodialysis

Jody A. Charnow January 09, 2012

Most men on hemodialysis (HD) have erectile dysfunction (ED) and do not receive treatment for the condition, a multinational study found.

Investigational Drug Helps Diabetics with ED

Jill Stein September 14, 2011

LISBON—Avanafil, an investigational, highly specific phosphodiesterase type 5 inhibitor, is an effective treatment for erectile dysfunction (ED) in men with diabetes, according to phase 3 data released at the 47th European Association for the Study of Diabetes annual meeting.

New Once-Daily Drug Shows Promise for ED

John Schieszer April 04, 2011

A once-daily dosing regimen with udenafil (Zydena), an experimental phosphodiesterase type 5 inhibitor, can significantly improve erectile function in men with erectile dysfunction (ED), according to a new Korean study published online in European Urology.

ED Drugs Can Ease Post-Op Urinary Incontinence

Rosemary Frei, MSc September 07, 2010

TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting of the International Continence Society and the International Urogynecological Association.

ED Signals Higher Death and Cardiovascular Risk

Delicia Honen Yard May 21, 2010

Erectile dysfunction (ED) is a strong predictor of all-cause mortality and the composite of cardiovascular death, heart attack, stroke, and heart failure in men with cardiovascular disease (CVD), according to the results of a worldwide study of 1,519 men with ED and CVD.

Erectile Dysfunction Signals Higher Death and Cardiovascular Risk

Delicia Honen Yard April 09, 2010

Erectile Dysfunction Levels Off Two Years After EBRT

Delicia Honen Yard March 26, 2010

For men who have had external beam radiotherapy (EBRT) for prostate cancer, the greatest decline in sexual function is in the first 24 months post-treatment, with no significant changes thereafter, according to a report in the International Journal of Radiation Oncology, Biology, Physics (2010;76:31-35).

Erectile Dysfunction, Restless Leg Syndrome Linked

Delicia Honen Yard January 20, 2010

Older men with restless leg syndrome (RLS) are more likely to have erectile dysfunction (ED) than men without RLS—and dopamine may be the common denominator, according to a study.

Severe Erectile Dysfunction Less Likely in Blacks and Asians

Jody A. Charnow January 15, 2010

Black men and Asian men are less likely to have severe erectile dysfunction (ED) than white men, according to a study of 78,445 men aged 45 to 69 years who were not diagnosed with prostate cancer.

Shock Wave Therapy Found to Relieve ED

Jill Stein January 01, 2010

LYON, FRANCE—Israeli researchers have reported promising preliminary results using low-intensity shock wave therapy to treat vasculogenic erectile dysfunction (ED).

Drug Found to Benefit Men With Peyronie's Disease

Jody A. Charnow December 15, 2009

Pentoxifylline sustained-release (PTX-SR) is moderately effective reducing penile curvature and plaque volume in men suffering from early Peyronie's disease, researchers concluded.

ED, Rheumatoid Arthritis Could Be Linked

Jill Stein December 10, 2009

PHILADELPHIA—Erectile dysfunction (ED) is more common in patients with rheumatic disease—especially rheumatoid arthritis (RA)—than in the general population, according to new findings by an Irish research team.

Erectile Dysfunction Drugs May Help Treat Cardiac Hypertrophy

Jody A. Charnow November 19, 2009

PDE-5 inhibitors block one of the enzymes that break down a chemical which stops heart muscle growth.

Commentary

Kidney Stone Prevention: 'Fact versus Fiction'

According to current estimates, kidney stones will develop in 1 in 10 people during their lifetime. This translates to nearly 30 million people in the United States. Clearly, prevention is paramount.